Given the critical need for novel interventions in NSCLC and the prognostic significance of the PI3K/AKT signaling axis, this study aimed to evaluate the anticancer efficacy of 2,3′-dihydroxy-5′-methoxystilbene. The gene discussed is PIK3CA; the disease is non-small cell lung carcinoma.